Cargando…
Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329044/ https://www.ncbi.nlm.nih.gov/pubmed/34079081 http://dx.doi.org/10.1038/s41416-021-01403-z |
| _version_ | 1783732415268651008 |
|---|---|
| author | Decaens, Thomas Barone, Carlo Assenat, Eric Wermke, Martin Fasolo, Angelica Merle, Philippe Blanc, Jean-Frédéric Grando, Véronique Iacobellis, Angelo Villa, Erica Trojan, Joerg Straub, Josef Bruns, Rolf Berghoff, Karin Scheele, Juergen Raymond, Eric Faivre, Sandrine |
| author_facet | Decaens, Thomas Barone, Carlo Assenat, Eric Wermke, Martin Fasolo, Angelica Merle, Philippe Blanc, Jean-Frédéric Grando, Véronique Iacobellis, Angelo Villa, Erica Trojan, Joerg Straub, Josef Bruns, Rolf Berghoff, Karin Scheele, Juergen Raymond, Eric Faivre, Sandrine |
| author_sort | Decaens, Thomas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8329044 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83290442021-08-19 Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression Decaens, Thomas Barone, Carlo Assenat, Eric Wermke, Martin Fasolo, Angelica Merle, Philippe Blanc, Jean-Frédéric Grando, Véronique Iacobellis, Angelo Villa, Erica Trojan, Joerg Straub, Josef Bruns, Rolf Berghoff, Karin Scheele, Juergen Raymond, Eric Faivre, Sandrine Br J Cancer Correction Nature Publishing Group UK 2021-06-02 2021-08-03 /pmc/articles/PMC8329044/ /pubmed/34079081 http://dx.doi.org/10.1038/s41416-021-01403-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Decaens, Thomas Barone, Carlo Assenat, Eric Wermke, Martin Fasolo, Angelica Merle, Philippe Blanc, Jean-Frédéric Grando, Véronique Iacobellis, Angelo Villa, Erica Trojan, Joerg Straub, Josef Bruns, Rolf Berghoff, Karin Scheele, Juergen Raymond, Eric Faivre, Sandrine Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression |
| title | Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression |
| title_full | Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression |
| title_fullStr | Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression |
| title_full_unstemmed | Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression |
| title_short | Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression |
| title_sort | correction: phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with met overexpression |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329044/ https://www.ncbi.nlm.nih.gov/pubmed/34079081 http://dx.doi.org/10.1038/s41416-021-01403-z |
| work_keys_str_mv | AT decaensthomas correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT baronecarlo correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT assenateric correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT wermkemartin correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT fasoloangelica correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT merlephilippe correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT blancjeanfrederic correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT grandoveronique correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT iacobellisangelo correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT villaerica correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT trojanjoerg correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT straubjosef correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT brunsrolf correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT berghoffkarin correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT scheelejuergen correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT raymonderic correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression AT faivresandrine correctionphase1b2trialoftepotinibinsorafenibpretreatedadvancedhepatocellularcarcinomawithmetoverexpression |